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Introduction: Alveolar rhabdomyosarcomas of the mediastinum in children are rarely reported. Multimodality
therapy including chemotherapy, surgery and radiotherapy make up the backbone of the treatment of childhood
rhabdomyosarcomas. Complete resection whenever achievable is an important prognostic factor. However,
complete resection of tumors in the mediastinum often poses a unique challenge to thoracic surgeons due to
their close proximity to important neurovascular structures. Complete resection may not always be possible and
judicious peri-operative planning and preparation are required to avoid creating unnecessary surgical morbidities
resulting in delay of adjuvant therapy.
Case presentation: A 4-month-old Chinese baby boy was presented to our hospital with stridor, shortness of
breath and episodes of cyanosis. Imaging studies found an anterior mediastinal mass compressing the trachea and
other neurovascular structures and he was diagnosed to have alveolar rhabdomyosarcoma. Our patient received
upfront chemotherapy and subsequently open resection of the mass was attempted via median sternotomy.
Intraoperatively, the mass had invaded into the great vessels, precluding a complete resection. Debulking surgery
was performed instead and our patient received timely postoperative chemoradiotherapy.
Conclusions: We report a rare case of childhood alveolar rhabdomyosarcoma of the mediastinum with vascular
invasion treated with chemoradiotherapy and debulking surgery. Complete resection was not possible due to the
close proximity to the great vessels. Different surgical approaches to the mediastinum have been reported in adults
and children alike. Regardless of the surgical access, the treatment of childhood rhabdomyosarcomas should be
individualized, with careful balance between surgical clearance and surgical morbidity.
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Rhabdomyosarcoma (RMS) is the commonest soft tissue
sarcoma in children and adolescents. Around 20% of
RMS is alveolar type, and is associated with poorer prog-
nosis. Treatment of RMS varies widely according to
histology, site and age of the patient. Despite the advent
of combined chemotherapy, complete surgical resection
remains an important prognostic factor in the overall* Correspondence: calvinng@surgery.cuhk.edu.hk
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num present a unique challenge to surgeons due to their
intimate relationship with various important neurovas-
cular structures. RMS in the mediastinum in pediatric
patients is rarely reported and experiences with resection
of cervicothoracic region tumors in childhood in general
have been limited. In this report, we present a rare case
of alveolar RMS of the anterior mediastinum with vascu-
lar invasion in a baby, and discuss the various con-
siderations in the surgical approach for children with
mediastinal tumors.icle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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A 4-month-old Chinese baby boy had experienced noisy
breathing for 2 months. He presented to the pediatrics
unit with increasing shortness of breath with episodes of
cyanosis. A computed tomography (CT) scan of his
chest with contrast enhancement revealed a 7 × 3 × 5cm
anterior mediastinal mass extending to the cervical re-
gion, compressing the trachea and veins as well as dis-
placing the aortic arch posteriorly (Fig. 1). An incisional
biopsy of the mass via an incision over the left cervical
strap muscles showed infiltrative loose clusters of tumor
cells among fibrous stroma. The tumor cells showed mod-
erate pleomorphism, inconspicious nucleoli and scanty in-
distinct cytoplasm. No rhabdomyoblasts were seen and no
alveolar pattern or teratomatous component was identi-
fied. The undifferentiated morphology was more com-
patible with alveolar rhabdomyosarcoma. The cells stained
strongly positive for vimentin, desmin and myogenin.
Total RNA was extracted from the tissue and reverse tran-
scription polymerase chain reaction (RT-PCR) detected
PAX3/FOXO1 fusion transcript, confirming the diagnosis
of alveolar-type rhabdomyosarcoma (Fig. 2).
Ultrasonography of the abdomen, a bone scan and
bone marrow study did not reveal any metastatic lesions.
Vincristine, actinomycin and cyclophosphamide were
commenced, with radiological evidence of tumor regres-
sion. After 11 weeks of chemotherapy, a CT scan of his
chest showed good response to chemotherapy with
shrinkage of the tumor. Our patient subsequently under-
went an exploratory median sternotomy at the age of 8
months.
A hard mass was found at the left superior part of the
anterior mediastinum along with a sizeable thymus. The
mass spanned from the lower border of the brachioce-
phalic vein to the neck and from the midline to the areaFig. 1 Computed tomographic view of the anterior mediastinal
mass compressing and displacing the trachea and great vesselsbetween the left brachiocephalic vein and left common
carotid artery. Total thymectomy with preservation of
the bilateral phrenic nerves was performed. Complete
excision of the tumor was attempted, but failed due to
tumor invasion of the left brachiocephalic vein and the
left common carotid artery. Debulking of the tumor was
performed leaving behind a small volume of residual
tumor in the area adjacent to the invaded great vessels
(Fig. 3). The site of the involved margin was marked
with clips.
A pathologic examination revealed an 8 × 5.5 × 0.8cm
tumor invading the thymus, with associated thyroid tis-
sue and skeletal muscle fibers (Fig. 4). Microscopic
examination was consistent with rhabdomyosarcoma.
Radiotherapy with a dose of 50.4 Gy was given to the
marked area of residual tumor. Unfortunately, a subse-
quent CT scan 9 months postoperatively and at week 39
of chemotherapy revealed tumor recurrence around the
surgical clip site, confirmed by biopsy. The tumor pro-
gressed rapidly despite further therapy and our patient
ultimately developed respiratory failure and died at the
age of 3.
Discussion
Rhabdomyosarcoma (RMS) is the commonest soft tissue
sarcoma in children [1]. The commonest histological
variants of RMS are the embryonal (ERMS) and alveolar
(ARMS) subtypes, the latter being less common and as-
sociated with poorer prognosis. RMS is comparatively
rare in adults, only accounting for <1% of all adult solid
tumor malignancies while about half of pediatric soft tis-
sue sarcomas are RMS, with slight male predominance.
More than two thirds of pediatric RMS is diagnosed be-
fore the age of 6. Common sites of occurrence for RMS
include the head and neck region, followed by the
genitourinary system and the extremities. Mediastinal
rhabdomyosarcomas are rare, and are often related to
germ cell or teratomatous tumors. To our knowledge
only a handful of mediastinal alveolar rhabdomyosar-
comas have been reported. Mediastinal rhabdomyo-
sarcomas tend to be larger and more locally invasive
than RMS in other regions and are associated with
poorer prognosis, with the majority of the cases reported
to have early local and distant recurrence post resection.
Specific chromosomal translocations are detected
in around 80% of cases of ARMS. Translocation
t(2;13)(q35;q14) occurs in 60% of ARMS, and trans-
location t(1;13)(p36;q14) occurs in approximately 20%.
These translocations result in the expression of trans-
cription factors PAX3-FOXO1 or PAX7-FOXO1, which
induce angiogenesis and activate cell proliferation. The
prognostic value of the presence of fusion gene PAX3-
FOXO1 in alveolar rhabdomyosarcoma is still under
debate and a latest meta-analysis did not find significant
Fig. 2 a The small round cell tumor arranged mainly in a predominantly solid pattern with a vague alveolar pattern noted focally (in the lower right
portion of the image). The majority of the tumor cells are primitive in appearance. Occasional tumor cells with more abundant brightly fibrillar
eosinophilic cytoplasm, consistent with rhabdomyoblasts (as indicated by arrows) are noted. (Hematoxylin and eosin stain, original magnification ×400).
b On immunohistochemistry, the tumor cells are positive for myogenin and indicative of rhabdomyogenic differentiation. (Immunohistochemical
staining for myogenin, original magnification ×400). c Typical fusion transcript of PAX3-FOXO1 was detected by reverse transcription polymerase chain
reaction, confirming the diagnosis of alveolar rhabdomyosarcoma
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positive and negative fusion gene. Indeed, better quality
studies are needed to validate its prognostic significance [2].
The treatment of RMS has evolved over decades. Mul-
timodality treatment protocols devised by large inter-
national cooperative groups such as the Intergroup
Rhabdomyosarcoma Study Group (IRSG) have improved
cure rates for RMS in children from 25% in the 1970s to
70% in the 1990s [3, 4]. This is mainly attributed to im-
proved combined chemotherapy, better and earlier sta-
ging and diagnosis, as well as improving local treatment
options including radiotherapy and surgery. The chemo-
therapy backbone of RMS therapy has been vincristine,
actinomycin and cyclophosphamide. Complete resection
of the tumor should be considered for all localized disease.
While diagnostic biopsy combined with neoadjuvanttherapy before definitive local treatment is an alternative
for initially unresectable disease, the role of debulking and
second-look surgery still remain uncertain.
Nonetheless, complete resection of tumors in the cer-
vicothoracic region remains a challenge to thoracic sur-
geons due to their close relationships with important
neurovascular and lymphoid structures. In order to bal-
ance completeness of resection with debilitating postop-
erative morbidity, comprehensive preoperative planning,
adequate surgical exposure and meticulous dissection
are often required for favorable outcomes. To date, experi-
ences with resection of childhood mediastinal tumors
have been limited to case series and reports [1, 3, 5].
Magnetic resonance imaging (MRI) is recognized to be
superior to CT in the assessment of tumor relations with
adjacent soft tissues. Various adult case series and
Fig. 3 Intraoperative view of the mediastinal bed following resection
showing the slung brachiocephalic vein, brachiocephalic artery
(labeled 1), trachea (2), esophagus (3), and tumor encasing the left
brachiocephalic vein and left common carotid artery (4)
Chow et al. Journal of Medical Case Reports  (2015) 9:157 Page 4 of 5reports of mediastinal sarcomas had MRI performed to
assess for degree of tumor encasement with respect to
adjacent great vessels. Vascular involvement is considered
absent if there is a less than 180 degree circumferential re-
lationship or a clear plane can be seen between the tumor
and vessel [6]. Nonetheless, preoperative radiology mayFig. 4 Resected specimen containing the bulky thymus and the
mediastinal tumor. The tumor is labeled A, with the orientation of
the mass markednot always identify important vascular invasion. In a case
series published recently by Christison-Lagay et al., a case
of tumor invasion into pulmonary artery was not identi-
fied until open surgery, ultimately resulting in aborted sur-
gery [5]. In our case, preoperative CT also did not show
conclusive evidence of tumor invasion into the great ves-
sels, and in view of the considerable tumor shrinkage post
neoadjuvant chemotherapy, resection surgery was hence
performed for our patient. No MRI was performed for this
baby, as the risk of general anesthesia, with a mediastinal
mass compressing the trachea, would have outweighed
the benefit of the scan. Worthy of note, the need for sed-
ation or general anesthesia in young children for MRI, in
our view, unlike RMS in other regions, carries a high risk
of respiratory failure in mediastinal RMS with visible tra-
cheal compression.
Methods of surgical approach and preservation of im-
portant neurovascular structures have been discussed and
published extensively in studies relating to resection of
adult cervicothoracic tumors. In contrast, similar reports
are very limited for childhood mediastinal tumors. Sauvat
et al. performed the transmanubrial osteomuscular-sparing
technique popularized by Grunenwald to achieve more
than 90% gross total resections in four children with
cervicothoracic neuroblastomas [7, 8]. This approach
is considered an alternative to Dartevelle’s anterior
transcervical-thoracic approach with reported lower inci-
dence of shoulder girdle dysfunction due to preservation
of the clavicle and sternoclavicular joint in adult lung can-
cer series [9, 10]. To date, the largest series concerning
childhood mediastinal tumors was published in 2014 by
Christison-Lagay et al. from the Sloan-Kettering Cancer
Center in New York [5]. They performed “trap-door” and
“clam shell” approaches to resection of various extensive
cervicothoracic tumors, mostly neuroblastomas, in 17
children with age ranging from 9 month to 29.6 years.
Total or near gross total resection was achieved in 94% of
patients. One case was unresectable due to invasion to the
pulmonary artery. No great vessel reconstruction was per-
formed in their experience. Two patients had patch angio-
plasty done for the brachiocephalic vein. Outcomes were
reported to be good with no chylothorax or vascular in-
jury, and absence of long-term neurological sequel. In our
case, we were able to clearly delineate, via a median ster-
notomy, that the tumor was adherent to the left common
carotid artery and closely related to the subclavian artery.
So far, there has been no study reporting vascular resec-
tion and reconstruction of great vessels in children <1 year
old with sarcomas. Isolated reports of left subclavian ar-
tery transfers and resection of Kommerell’s diverticulum
can be found in the literature, but childhood great vessels
reconstruction post tumor resection remains largely unex-
plored with very little known on the topic [11]. We decided
not to attempt gross resection with multiple great vessel
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the considerable risks and lack of supporting literature.
The need to extend the median sternotomy or convert to a
trap-door-type incision was therefore not necessary as this
could have potentially introduced further morbidities,
which may have delayed further chemoradiotherapy.Conclusions
In conclusion, the management of mediastinal sarcoma
remains challenging to both oncologists and surgeons.
Reports of surgical resection in the literature for child-
hood, in particular childhood mediastinal rhabdomyosar-
coma, are rare. Although complete resection is desirable,
a proportion achieves only near-complete resection.
Whatever the surgical access, some infant mediastinal
tumors are found unresectable intraoperatively, usually
because of vascular invasion. The risk and benefit be-
tween achieving complete resection and postoperative
morbidity leading to delays in chemoradiotherapy must
be weighed and balanced accordingly. Ultimately, the
management of each case of mediastinal sarcoma should
be individualized and multidisciplinary.Consent
Written informed consent was obtained from the patient’s
legal guardian(s) for publication of this case report and any
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